Insmed Inc. buy JPMorgan Chase & Co.
Start price
07.02.25
/
50%
€77.50
Target price
07.02.26
€89.05
Performance (%)
76.77%
Price
22.01.26
€133.00
Summary
This prediction is currently active. With a performance of 76.77% the BUY prediction by JPMorgan_Chase___Co_ is a big success. This prediction currently runs until 07.02.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -2.920% | -2.920% |
| iShares Core DAX® | -1.673% | 2.237% |
| iShares Nasdaq 100 | -1.346% | 0.290% |
| iShares Nikkei 225® | -1.529% | 5.863% |
| iShares S&P 500 | -1.702% | 0.697% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $83.00 to $92.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat